학술논문

A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced with AdGMCA9 (DC-AdGMCAIX) in Patients with Metastatic Renal Cell Carcinoma
Document Type
Article
Source
In: Journal of Immunotherapy. (Journal of Immunotherapy, 1 November 2020, 43(9):273-282)
Subject
Language
English
ISSN
15374513
15249557